Shop All Cytogenetics Reagents
AmnioMAX™ C-100 Supplement (Gibco™)
Gibco® AmnioMAX™ C-100 Supplement is part of a kit used to prepare a fully-supplemented Gibco® AmnioMAX™ C-100 Complete Medium developed for the short term culture of human amniotic fluid cells for cytogenetic studies and in vitro diagnostic procedures.
Gibco® AmnioMAX™ C-100 Complete Medium features:
• Easy-to-use format
• Quality and performance testing
• Unique, optimized formulation
Easy-to-use format
Gibco® AmnioMAX™ C-100 Complete Medium is a two-part kit for preparation of a complete medium that requires no additional supplementation. The complete medium can be stored at 2–8°C for up to ten days.
Quality and performance testing
Every lot of Gibco® AmnioMAX™ C-100 Complete Medium is performance tested by a certified US reference cytogenetics laboratory to ensure consistently superior performance. Pooled primary human amniotic fluid samples are cultured for six days in Gibco® AmnioMAX™ C-100 Complete Medium before measuring the total number of colonies and total number of mitotic colonies. In addition, each lot is tested for sterility, pH and osmolality.
Unique, optimized formulation
Gibco® AmnioMAX™ C-100 Complete Medium contains Fetal Bovine Serum (FBS), gentamicin, and L-glutamine to maximize cell attachment and growth. This optimized medium also has an enhanced buffering system that provides greater pH stability during culture manipulations.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® AmnioMAX™ C-100 Supplement is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
Gibco® AmnioMAX™ C-100 Complete Medium features:
• Easy-to-use format
• Quality and performance testing
• Unique, optimized formulation
Easy-to-use format
Gibco® AmnioMAX™ C-100 Complete Medium is a two-part kit for preparation of a complete medium that requires no additional supplementation. The complete medium can be stored at 2–8°C for up to ten days.
Quality and performance testing
Every lot of Gibco® AmnioMAX™ C-100 Complete Medium is performance tested by a certified US reference cytogenetics laboratory to ensure consistently superior performance. Pooled primary human amniotic fluid samples are cultured for six days in Gibco® AmnioMAX™ C-100 Complete Medium before measuring the total number of colonies and total number of mitotic colonies. In addition, each lot is tested for sterility, pH and osmolality.
Unique, optimized formulation
Gibco® AmnioMAX™ C-100 Complete Medium contains Fetal Bovine Serum (FBS), gentamicin, and L-glutamine to maximize cell attachment and growth. This optimized medium also has an enhanced buffering system that provides greater pH stability during culture manipulations.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® AmnioMAX™ C-100 Supplement is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
KaryoMAX™ Potassium Chloride Solution (Gibco™)
Gibco® KaryoMAX® Potassium Chloride Solution is a 0.075 M hypotonic solution for enlarging cells to facilitate the spreading of metaphase chromosomes for karyotyping. Gibco® KaryoMAX® Potassium Chloride Solution is formulated as 5.592 g potassium chloride per liter distilled water.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Potassium Chloride Solution is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Potassium Chloride Solution is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
Phytohemagglutinin, M form (PHA-M) (Gibco™)
La phytohémagglutinine Gibco®, forme M (PHA-M) est une solution faite à partir d’un extrait brut du haricot rouge Phaseolus vulgaris. Cet extrait est capable d’induire une blastogenèse in vitro dans diverses cellules de mammifère mononucléaires lorsqu’il est utilisé à une concentration de 1 à 2 % v/v. La performance de chaque lot de phytohémagglutinine Gibco® est testée à 1,5 % à l’aide de lymphocytes sanguins périphériques provenant d’un donneur adulte normal et cultivés pendant 72 heures dans le milieu de culture Gibco® RPMI 1640 supplémenté de sérum de veau fœtal (SVF), d’héparine, d’antibiotiques et de L-glutamine.
Fabrication et système de qualité conformes aux BPFa
La phytohémagglutinine Gibco® est fabriquée sur un site conforme aux BPFa et situé à Grand Island, New York (États-Unis). Le site est homologué par la FDA comme fabricant de dispositifs médicaux et il est certifié ISO 13485.
Fabrication et système de qualité conformes aux BPFa
La phytohémagglutinine Gibco® est fabriquée sur un site conforme aux BPFa et situé à Grand Island, New York (États-Unis). Le site est homologué par la FDA comme fabricant de dispositifs médicaux et il est certifié ISO 13485.
KaryoMAX™ Giemsa Stain Solution (Gibco™)
Gibco® KaryoMAX® Giemsa Stain Solution is a solution used for G-banding of chromosomes for cytogenetic analysis. Gibco® KaryoMAX® Giemsa Stain Solution is formulated as 6.0 g Azur II Eosin and 1.6 g Azur II per liter in glycerol/methanol.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Giemsa Stain Solution is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Giemsa Stain Solution is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
eBioscience™ Phytohemagglutinin-L (PHA-L) Solution (500X) (Invitrogen™)
La solution Phytohemagglutinin-L (PHA-L) Solution (500X) est une solution prête à l’emploi de PHA-L diluée dans un tampon aqueux. La phytohémagglutinine (PHA) est un mélange de lectines extraites du haricot rouge, Phaseolus vulgaris. La PHA-L est une fraction de la PHA qui présente une forte activité d’agglutination des leucocytes et une forte activité mitogène, mais une très faible activité d’agglutination des érythrocytes. Destiné à une utilisation in vitro, ce réactif permet d’activer les leucocytes humains et murins.
Gurr Buffer Tablets (Gibco™)
Gibco® Gurr Buffer Tablets offer a convenient way to prepare a pH 6.8 phosphate buffer for dilution of Giemsa stain used in G-banding of chromosomes for cytogenetic analysis. Simply add one buffer tablet to one liter of distilled water and stir until dissolved.
KaryoMAX™ Colcemid™ Solution in HBSS (Gibco™)
La solution Gibco® KaryoMAX® Colcemid™ dans HBSS est une solution de 10 µg/ml de N-désacétyle-N-méthylocolchicine (Colcemid™) préparée dans une solution saline équilibrée de Hank (HBSS). La solution Colcemid™ empêche la formation de fuseaux au cours de la mitose. Elle bloque les cellules de la métaphase de façon à séparer les chromosomes à des fins d’études cytogénétiques et de procédures de diagnostic in vitro. Le mécanisme d’action est similaire à celui de la colchicine mais sa toxicité pour les mammifères est moindre.
La formulation complète est disponible.
Fabrication et système de qualité conformes aux BPFa
La solution Gibco® KaryoMAX® Colcemid™ dans HBSS est fabriquée sur un site conforme aux BPFa et situé à Grand Island, New York (États-Unis). Le site est homologué par la FDA comme fabricant de dispositifs médicaux et il est certifié ISO 13485.
La formulation complète est disponible.
Fabrication et système de qualité conformes aux BPFa
La solution Gibco® KaryoMAX® Colcemid™ dans HBSS est fabriquée sur un site conforme aux BPFa et situé à Grand Island, New York (États-Unis). Le site est homologué par la FDA comme fabricant de dispositifs médicaux et il est certifié ISO 13485.
KaryoMAX™ Colcemid™ Solution in PBS (Gibco™)
Gibco® KaryoMAX® Colcemid™ Solution in PBS is a 10 µg/ml N-desacetyl-N-methylocolchicine (Colcemid™) solution made in Phosphate Buffered Saline (PBS). It is used for arresting cells in metaphase so the chromosomes can be separated for cytogenetic studies and in vitro diagnostic procedures. Colcemid™ prevents spindle formation during mitosis, causing metaphase arrest. The mechanism of action is similar to that of colchicine, but with lower mammalian toxicity. The complete formulation is available.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Colcemid™ Solution in PBS is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
Product Use
For in vitro diagnostic use.
cGMP Manufacturing and Quality System
Gibco® KaryoMAX® Colcemid™ Solution in PBS is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
